NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Insulin and Oral Hypoglycemics
    Insulin and Oral Hypoglycemics
    medium

    A 52-year-old man with type 2 diabetes mellitus on metformin monotherapy presents with progressive fatigue, paresthesias, and macrocytic anemia (Hb 9.2 g/dL, MCV 108 fL). Serum creatinine is 1.8 mg/dL. Which investigation is most appropriate to confirm the suspected diagnosis?

    A. Serum vitamin B12 and methylmalonic acid levels
    B. Peripheral blood smear and reticulocyte count
    C. Tissue transglutaminase (tTG) IgA antibodies
    D. Intrinsic factor antibodies and parietal cell antibodies

    Explanation

    ## Clinical Presentation Analysis The patient presents with a classic triad suggestive of metformin-associated vitamin B12 deficiency: - **Neurological symptoms:** paresthesias (peripheral neuropathy) - **Hematological findings:** macrocytic anemia (MCV >100 fL) - **Biochemical context:** prolonged metformin use with renal impairment (eGFR ~35 mL/min/1.73m²) ## Mechanism of Metformin-Induced B12 Deficiency **Key Point:** Metformin impairs vitamin B12 absorption in the terminal ileum by: 1. Reducing calcium-dependent B12 binding to intrinsic factor 2. Altering gut microbiota composition 3. Decreasing gastric intrinsic factor secretion (less common) Renal impairment accelerates metformin accumulation, increasing the risk of B12 malabsorption. ## Diagnostic Approach | Investigation | Role | Why Chosen Here | | --- | --- | --- | | **Serum B12 + methylmalonic acid** | Gold standard for B12 deficiency confirmation | Serum B12 may be low-normal; MMA is elevated in true B12 deficiency, distinguishing from folate deficiency | | Peripheral smear + reticulocyte | Characterizes anemia morphology | Non-specific; does not confirm B12 deficiency etiology | | IF/parietal cell antibodies | Diagnostic for pernicious anemia | Metformin-induced B12 deficiency is malabsorptive (not autoimmune); antibodies will be negative | | tTG IgA | Screens for celiac disease | Unrelated to metformin; celiac causes B12 deficiency but no mention of GI symptoms or serologic clues | ## High-Yield Facts **High-Yield:** Metformin-induced B12 deficiency occurs in 10–30% of long-term users, especially with: - Renal impairment (eGFR <45 mL/min/1.73m²) - Prolonged therapy (>4 years) - Achlorhydria or PPI use (additive effect) **Clinical Pearl:** Methylmalonic acid (MMA) is the most specific marker of B12 deficiency because it accumulates only when B12-dependent methylmalonyl-CoA mutase is impaired. Serum B12 alone can be falsely reassuring in early deficiency. **Mnemonic: B12 Confirmation** — **MMA** = **M**ethylmalonic acid (most specific), **H**omocysteine (elevated in both B12 and folate deficiency, less specific).

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free